CMS certification 314011
University Behavioral Health Care
671 Hoes Lane West, Piscataway, NJ 08854
This page brings together federal quality data for this hospital: its CMS star rating, patient survey results, emergency department times, and death, complication, infection and readmission rates, each compared with the national rate. Everything here comes from CMS and NPPES, the federal sources themselves - not from us.
Clinicians registered at this address
518 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 42 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Mental Health | 117 |
| Clinical | 77 |
| Social Worker | 62 |
| Registered Nurse | 50 |
| Case Manager/Care Coordinator | 49 |
| Professional | 42 |
| Psychiatry | 32 |
| Psychologist | 20 |
| Counselor | 16 |
| Addiction (Substance Use Disorder) | 8 |
| Child & Adolescent Psychiatry | 7 |
| Pharmacist | 5 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $155,646
- 2020 $27,000
- 2021 $190,718
- 2022 $100,307
- 2023 $132,509
- 2024 $25,922
- 2025 $165,514
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Royalties and licensing fees | $82,390 | 4 |
| Grants | $11,814 | 1 |
| Space rental and facility fees | $2,500 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $104,510 | 19 |
| Straumann USA LLC | $49,190 | 2 |
| Merit Medical Systems Inc | $11,814 | 1 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| CR2023-01 Site Rutgers Straumann USA LLC | $40,690 |
| A STUDY OF TAK-755 (RADAMTS13) WITH LITTLE TO NO PLASMA EXCHANGE (PEX) TREATMENT IN ADULTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (… Takeda Pharmaceuticals U.S.A., Inc. | $13,366 |
| Non-abrasive treatment of peri-implantitis using enamel matrix derivative Straumann USA LLC | $8,500 |
| PARADIGHM A NATURAL HISTORY REGISTRY FOR PATIENTS WITH CHRONIC HYPOPARATHYROIDISM Takeda Pharmaceuticals U.S.A., Inc. · NCT01922440 | $6,255 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
Common questions about University Behavioral Health Care
Does University Behavioral Health Care have an emergency room?
Yes. CMS lists emergency services at University Behavioral Health Care.
Does University Behavioral Health Care receive money from drug and device companies?
Drug and device makers reported $165,514 in payments to University Behavioral Health Care for 2025, under the federal Open Payments program. A payment on its own does not show a conflict of interest.